Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry

EuroIntervention

Volumn 13, Issue 15, 2018, Pages e1764-e1770

  Möllmann, Helge ^a,b   Hengstenberg, Christian ^c,d,e   Hilker, Michael ^f   Kerber, Sebastian ^g   Schäfer, Ulrich ^h   Rudolph, Tanja ⁱ   Linke, Axel ^j   Franz, Norbert ^k   Kuntze, Thomas ^l   Nef, Holger ^m   Kappert, Utz ⁿ   Walther, Thomas ^a   Zembala, Michael O ^o   Toggweiler, Stefan ^p   Kim, Won Keun ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Partner Site Munich Heart Alliance   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g Cardiovascular Clinic Bad Neustadt   (Germany)

^h UNIVERSITY HEART CENTER HAMBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^j UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^k Schüchtermann schiller'Sche Kliniken GmbH   (Germany)

^l Central Hospital Bad Berka   (Germany)

^m UNIVERSITY HOSPITAL GIESSEN   (Germany)

ⁿ University Heart Center Dresden   (Germany)

^o MEDICAL UNIVERSITY OF SILESIA   (Poland)

^p LUZERNER KANTONSSPITAL   (Switzerland)

more..

Author keywords

Aortic stenosis; Femoral; Transcatheter aortic valve implantation (TAVI)

Indexed keywords

AGED; AORTIC STENOSIS; ARTICLE; CALCIFICATION; CARDIOVASCULAR RESPONSE; CLINICAL EFFECTIVENESS; DEVICE SAFETY; ECHOCARDIOGRAPHY; GENERAL ANESTHESIA; HUMAN; MORTALITY; PACEMAKER IMPLANTATION; PARAVALVULAR LEAK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; ADVERSE EVENT; AORTIC VALVE; AORTIC VALVE STENOSIS; ARTIFICIAL HEART PACEMAKER; BIOPROSTHESIS; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DEVICES; DIAGNOSTIC IMAGING; DISABILITY; EUROPE; FEMALE; FEMORAL ARTERY; HEART ARRHYTHMIA; HEART PACING; HEART VALVE PROSTHESIS; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PROSTHESIS DESIGN; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; BALLOON VALVULOPLASTY; BIOPROSTHESIS; CARDIAC PACING, ARTIFICIAL; CATHETERIZATION, PERIPHERAL; DISABILITY EVALUATION; EUROPE; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85041675633     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJ-D-17-00628     Document Type: Article

References (24)

1. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62:1002-12.
2. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, Gohlke-Barwolf C, Boersma E, Ravaud P, Vahanian A. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26:2714-20.
3. Gaede L, Kim WK, Blumenstein J, Liebetrau C, Dörr O, Nef H, Hamm C, Walther T, Achenbach S, Elsässer A, Möllmann H. Temporal trends in transcatheter and surgical aortic valve replacement: An analysis of aortic valve replacements in Germany during 2012-2014. Herz. 2017;42:316-24.
4. Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S, Mohr FW, Walther T. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA)™: 6-month outcomes. Eur J Cardiothorac Surg. 2013;43:52-6.
5. Börgermann J, Holzhey DM, Thielmann M, Girdauskas E, Schroefel H, Hofmann S, Treede H, Matschke K, Hilker M, Strauch JT, Carrel T, Wahlers T, Diegeler A, Kempfert J, Walther T. Transcatheter aortic valve implantation using the ACURATE TA™ system: 1-year outcomes and comparison of 500 patients from the SAVI registries. Eur J Cardiothorac Surg. 2017;51:936-42.
6. Schäfer U, Conradi L, Diemert P, Deuschl F, Schofer N, Seiffert M, Lubos E, Schirmer J, Reichenspurner H, Blankenberg S, Treede H. Symetis ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve. Minerva Cardioangiol. 2015;63:359-69.
7. Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACURATE TF™ aortic bioprosthesis. EuroIntervention. 2013;9 Suppl:S107-10.
8. Kappetein AP, Head SJ, Généreux P, Piazza N, Van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33:2403-18.
9. Möllmann H, Walther T, Siqueira D, Diemert P, Treede H, Grube E, Nickenig G, Baldus S, Rudolph T, Kuratani T, Sawa Y, Kempfert J, Kim WK, Abizaid A. Transfemoral TAVI using the self-expanding ACURATE neo prosthesis: one-year outcomes of the multicentre "CE-approval cohort". EuroIntervention. 2017;13: e1040-6.
10. Hamm K, Reents W, Zacher M, Kerber S, Diegeler A, Schieffer B, Barth S. Transcatheter aortic valve implantation using the ACURATE TA and ACURATE neo valves: a four-year singlecentre experience. EuroIntervention. 2017;13:53-9.
11. Noble S, Stortecky S, Heg D, Tuller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grunenfelder J, Juni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M. Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroIntervention. 2017;12:e2170-6.
12. Naber CK, Pyxaras SA, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, Den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck KH, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner D, Latib A, De Marco F, Kische S. A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis. EuroIntervention. 2016;12: e1413-9.
13. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A. SOURCE 3 Registry: Design and 30-Day Results of the European Post Approval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve. Circulation. 2017;135:1123-1132.
14. Falk V, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Linke A, Ince H, Wenaweser P, Allocco DJ, Dawkins KD, Van Mieghem NM. Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study. Eur Heart J. 2017;38: 3359-66.
15. Manoharan G, Linke A, Moellmann H, Redwood S, Frerker C, Kovac J, Walther T. Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system. EuroIntervention. 2016;12: 768-74.
16. Möllmann H, Linke A, Holzhey DM, Walther T, Manoharan G, Schäfer U, Heinz-Kuck K, Van Boven AJ, Redwood SR, Kovac J, Butter C, Søndergaard L, Lauten A, Schymik G, Worthley SG. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. JACC Cardiovasc Interv. 2017;10:1538-47.
17. Toggweiler S, Nissen H, Mogensen B, Cuculi F, Fallesen C, Veien KT, Brinkert M, Kobza R, Rück A. Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation. EuroIntervention. 2017;13:1273-80.
18. Naber CK, Pyxaras SA, Ince H, Latib A, Frambach P, den Heijer P, Wagner D, Butter C, Colombo A, Kische S. Real-world multicentre experience with the Direct Flow Medical repositionable and retrievable transcatheter aortic valve implantation system for the treatment of high-risk patients with severe aortic stenosis. EuroIntervention. 2016;11:e1314-20.
19. Webb J, Gerosa G, Lefèvre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64:2235-43.
20. Barbanti M, Petronio AS, Ettori F, Latib A, Bedogni F, De Marco F, Poli A, Boschetti C, De Carlo M, Fiorina C, Colombo A, Brambilla N, Bruschi G, Martina P, Pandolfi C, Giannini C, Curello S, Sgroi C, Gulino S, Patane M, Ohno Y, Tamburino C, Attizzani GF, Immè S, Gentili A, Tamburino C. 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis. JACC Cardiovasc Interv. 2015;8:1084-91.
21. Hahn RT, Pibarot P, Webb J, Rodes-Cabau J, Herrmann HC, Williams M, Makkar R, Szeto WY, Main ML, Thourani VH, Tuzcu EM, Kapadia S, Akin J, McAndrew T, Xu K, Leon MB, Kodali SK. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). JACC Cardiovasc Interv. 2014;7: 781-9.
22. Nombela-Franco L, Webb JG, de Jaegere PP, Toggweiler S, Nuis RJ, Dager AE, Amat-Santos IJ, Cheung A, Ye J, Binder RK, van der Boon RM, Van Mieghem N, Benitez LM, Pérez S, Lopez J, San Roman JA, Doyle D, Delarochellière R, Urena M, Leipsic J, Dumont E, Rodés-Cabau J. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation. 2012;126:3041-53.
23. Nombela-Franco L, Rodés-Cabau J, Delarochellière R, Larose E, Doyle D, Villeneuve J, Bergeron S, Bernier M, Amat-Santos IJ, Mok M, Urena M, Rheault M, Dumesnil J, Cote M, Pibarot P, Dumont E. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5:499-512.
24. Daneault B, Koss E, Hahn RT, Kodali S, Williams MR, Généreux P, Paradis JM, George I, Reiss GR, Moses JW, Smith CR, Leon MB. Efficacy and safety of postdilatation to reduce paravalvular regurgitation during balloon-expandable transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2013;6:85-91.